Andrew Craig Miller - May 10, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Operating Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
May 10, 2021
Transactions value $
-$506,150
Form type
4
Date filed
5/12/2021, 05:29 PM
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $46K +5K +10.99% $9.20* 50.5K May 10, 2021 Direct
transaction KRTX Common Stock Sale -$552K -5K -9.9% $110.43 45.5K May 10, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -5K -1.64% $0.00 300K May 10, 2021 Common Stock 5K $9.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.